Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
Speaker
Prof. Charlotte Teunissen
Professor in Neurochemistry
Charlotte Teunissen’s drive is to improve the care of patients with neurological diseases by developing body fluid biomarkers for diagnosis, stratification, prognosis, and monitoring treatment responses.
Julius Clinical and Amsterdam UMC are proud to present the webinar:
Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
During this webinar, Charlotte Teunissen, Professor in Neurochemistry at Amsterdam UMC touched upon:
- Patient selection
- Patient stratification
- Outcome measures
Related webinars
Webinar: Real-World Data in ALS
On 30 May, we hosted the webinar "Real-World Data in ALS", in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective ...
Webinar: Selecting and successfully integrating cognitive testing into clinical trials
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trialsDuring this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed:Cognitive domains – which ones sho...
Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL Questionnaire
In collaboration with our partner Brain Research Center, we presented the webinar: Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL QuestionnaireSpeakers:Dr. Sietske Sikkes | Associate Professor a...